"The findings from this large international sample provide strong support for physical activity across all ages of the lifespan, and the benefits of physical activity appear to be sustained and may be enhanced with aging."
Despite a median treatment time of 9.5 hours after stroke onset - more than twice the current therapeutic window - JX10 showed significantly better functional outcomes than placebo with no symptomatic intracranial hemorrhage events.